Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Scope of the Report:
This report focuses on the Contract Pharmaceutical Manufacturing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and so on, which required for pharmaceutical manufacturing. The main type of contract pharmaceutical manufacturing is API and FDF.
The contract pharmaceutical manufacturing industry is not very concentrated the revenue of top eighteenth manufacturers account about 22% of global revenue.
In the world wide, the major manufactures mainly distribute in North America and Europe. The transnational companies, like Catalent and DPx, are the leading manufactures in the World.
North America and Europe is the industry’s leading region. In 2015, the revenue of contract pharmaceutical manufacturing is about 19 billion USD in North America; its proportion of total global revenue exceeds 32%. In 2015, the revenue is about 14 billion USD in Europe. Japan and India have witnessed a major chunk developing of the contract pharmaceutical manufacturing in the Asia region. Especially India, its revenue is 8 billion USD in 2015.
The worldwide market for Contract Pharmaceutical Manufacturing is expected to grow at a CAGR of roughly 5.8% over the next five years, will reach 96400 million US$ in 2023, from 68700 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global Contract Pharmaceutical Manufacturing market.
Chapter 1, to describe Contract Pharmaceutical Manufacturing Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Contract Pharmaceutical Manufacturing, with sales, revenue, and price of Contract Pharmaceutical Manufacturing, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Contract Pharmaceutical Manufacturing, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Contract Pharmaceutical Manufacturing market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Contract Pharmaceutical Manufacturing sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source